Prevalence of HIV in the US household population: The national health and nutrition examination surveys, 1988 to 2002

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 5, 2006, Pages 651-656

  McQuillan, Geraldine M ^a   Kruszon Moran, Deanna ^a   Kottiri, Benny J ^a   Kamimoto, Laurie A ^b   Lam, Lee ^b   Cowart, M Faye ^b   Hubbard, Marjorie ^b   Spira, Thomas J ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV antibody; National survey; Prevalence

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ANTIBODY;

ADULT; AFRICAN AMERICAN; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DRUG ABUSE; ETHNIC GROUP; FEMALE; GENDER; HEALTH SURVEY; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREND STUDY; UNITED STATES; URINALYSIS;

AGE DISTRIBUTION; ETHNIC GROUPS; FAMILY CHARACTERISTICS; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; POVERTY; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33646787477     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000194235.31078.f6     Document Type: Review

References (28)

1. McQuillan GM, Khare M, Ezzatti-Rice TM, et al. The seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr. 1994;7:1195-1201.
2. McQuillan GM, Khare M, Karon JM, et al. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr. 1997;14:355-360.
3. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR. 2003;52:329-332.
4. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001;91:1060-1068.
5. National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat 1. 1994;32.
6. National Center for Health Statistics. NHANES 1999-2002. Available at: http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed March 29, 2005.
7. Bureau of the Census. Poverty in the United States: 1990. In: Current Population Reports, Series P-60. Washington, DC:US Government Printing Office; 1991.
8. National Center for Health Statistics. NHANES 1999-2000 prescription medication questionnaire file documentation. Available at: http://www.cdc.gov/ nchs/data/nhanes/frequency/rxq_rxdoc.pdf. Accessed July 29, 2004.
9. Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR. 1989;38(S-7):1-7.
10. Berrios DC, Avins AL, Haynes-Sanstad K, et al. Screening for human immunodeficiency virus antibody in urine. Arch Pathol Lab Med. 1995;119:139-141.
11. Fiebig EW, Johnson DK, Hirschkorn DF, et al. Lymphocyte subset analysis on frozen whole blood. Cytometry. 1997;29:340-350.
12. Lee FK, Coleman M, Pereira L, et al. Detection of herpes simplex virus type-2-specific antibody with glycoprotein G. J Clin Microbiol. 1985;22:641-644.
13. Mohadjer L, Montaquila J, Waksberg J. National Health and Nutrition Examination Survey III: weighting and examination methodology. Prepared by Westat for National Center for Health Statistics, Hyattsville, MD. February 1996.
14. Shah BV, Barnwell BG, Bieler GS, et al. SUDAAN Users Manual, release 7.0 [computer program]. Research Triangle Park, NC: Research Triangle Institute; 1996.
15. Wolter K. Introduction to Variance Estimation. New York: Springer-Verlag; 1985.
16. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press; 1989.
17. National Center for Health Statistics. NHANES 1999-2002. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_general_guidelines_june_04.pdf. Accessed March 29, 2005.
18. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003 [abstract 595]. Presented at: National HIV Prevention Conference, 2005, Atlanta.
19. Centers for Disease Control and Prevention. National HIV Prevalence Surveys, 1997 Summary. Atlanta: Centers for Disease Control and Prevention; 1998:1-25.
20. Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. JAMA. 2000;284:198-204.
21. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:643-654.
22. Strathdee SA, Galai N, Safaiean M. Sex differences in risk factors for HIV seroconversion among injection drug users. Arch Intern Med. 2001;161:1281-1288.
23. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45-52.
24. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS. 2002;16:2425-2430.
25. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes. 2001;8:46-49.
26. Centers for Disease Control and Prevention. HIV strategic plan through 2005. Available at: http://www.cdc.gov/nchstp/od/hiv_plan/default.htm. Accessed March 29, 2005.
27. Sanders GD, Ahmed MB, Sundaram V, et al. Cost effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-585.
28. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med. 2005;352:586-595.